Evidence map›Paper›PMID 38373022›Full record

Trial reportJournal of medical Internet research2024

Reliability of Telepsychiatry Assessments Using the Attention-Deficit/Hyperactivity Disorder Rating Scale-IV for Children With Neurodevelopmental Disorders and Their Caregivers: Randomized Feasibility Study.

Shunya Kurokawa, Kensuke Nomura, Nana Hosogane, Takashi Nagasawa, Yuko Kawade, Yu Matsumoto, Shuichi Morinaga, Yuriko Kaise, Ayana Higuchi, Akiko Goto and 3 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of medical Internet research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shunya KurokawaDepartment of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan.ORCID 0000-0001-6451-5263
Kensuke NomuraDepartment of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan.ORCID 0009-0007-1118-2128
Nana HosoganeDepartment of Child and Adolescent Mental Health, Aiiku Clinic, Tokyo, Japan.ORCID 0000-0002-8543-1103
Takashi NagasawaDepartment of Child and Adolescent Psychiatry, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.ORCID 0009-0002-3380-6206
Yuko KawadeDepartment of Child Psychiatry, Shimada Ryoiku Medical Center for Challenged Children, Tokyo, Japan.ORCID 0009-0000-9829-047X
Yu MatsumotoDepartment of Child Psychiatry, Shimada Ryoiku Medical Center for Challenged Children, Tokyo, Japan.ORCID 0009-0009-5439-685X
Shuichi MorinagaDepartment of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan.ORCID 0009-0005-4018-8997
Yuriko KaiseDepartment of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan.ORCID 0009-0005-2161-6968
Ayana HiguchiDepartment of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan.ORCID 0009-0005-7268-8953
Akiko GotoTsurugaoka Garden Hospital, Tokyo, Japan.ORCID 0009-0006-9196-8536
Naoko InadaDepartment of Clinical Psychology, Taisho University, Tokyo, Japan.ORCID 0009-0001-8203-783X
Masaki KodairaDepartment of Child and Adolescent Mental Health, Aiiku Clinic, Tokyo, Japan.ORCID 0000-0001-9186-5058
Taishiro KishimotoHills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.ORCID 0000-0003-0557-8648

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGiven the global shortage of child psychiatrists and barriers to specialized care, remote assessment is a promising alternative for diagnosing and managing attention-deficit/hyperactivity disorder (ADHD). However, only a few studies have validated the accuracy and acceptability of these remote methods.

objectiveThis study aimed to test the agreement between remote and face-to-face assessments.

methodsPatients aged between 6 and 17 years with confirmed Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition diagnoses of ADHD or autism spectrum disorder (ASD) were recruited from multiple institutions. In a randomized order, participants underwent 2 evaluations, face-to-face and remotely, with distinct evaluators administering the ADHD Rating Scale-IV (ADHD-RS-IV). Intraclass correlation coefficient (ICC) was used to assess the reliability of face-to-face and remote assessments.

resultsThe participants included 74 Japanese children aged between 6 and 16 years who were primarily diagnosed with ADHD (43/74, 58%) or ASD (31/74, 42%). A total of 22 (30%) children were diagnosed with both conditions. The ADHD-RS-IV ICCs between face-to-face and remote assessments showed "substantial" agreement in the total ADHD-RS-IV score (ICC=0.769, 95% CI 0.654-0.849; P<.001) according to the Landis and Koch criteria. The ICC in patients with ADHD showed "almost perfect" agreement (ICC=0.816, 95% CI 0.683-0.897; P<.001), whereas in patients with ASD, it showed "substantial" agreement (ICC=0.674, 95% CI 0.420-0.831; P<.001), indicating the high reliability of both methods across both conditions.

conclusionsOur study validated the feasibility and reliability of remote ADHD testing, which has potential benefits such as reduced hospital visits and time-saving effects. Our results highlight the potential of telemedicine in resource-limited areas, clinical trials, and treatment evaluations, necessitating further studies to explore its broader application.

trial registrationUMIN Clinical Trials Registry UMIN000039860; http://tinyurl.com/yp34x6kh.

Indexed as

Attention Deficit Disorder with HyperactivityAutism Spectrum DisorderNeurodevelopmental DisordersPsychiatryTelemedicineAdolescentCaregiversChildFeasibility StudiesHumansReproducibility of ResultsacceptabilityADHDapplicationattention-deficit/hyperactivity disorderautismautism spectrum disorderschildchildrendiagnosismanagementneurodevelopmentalneurodevelopmental disorderpsychiatristsreliabilitytelepsychitatry

Identifiers

PMID38373022
PMCPMC10912982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.